Cutaneous mucormycosis of the upper extremity in an immunocompetent host: case report.
Cutaneous mucormycosis, a relatively common infection in immunocompromised patients, remains rare in the immunocompetent patient outside the setting of major trauma. We report a case of an immunocompetent patient who developed left upper extremity Rhizopus infection following arterial puncture. Treatment included surgical debridement, liposomal amphotericin B, and hyperbaric oxygen wound therapy; the patient recovered fully. A review of the literature of cases of upper extremity Mucor infection is included for context. We feel that a high degree of suspicion for Mucor infection is warranted in patients with the described risk factors who do not respond to first-line antibiotics.
College of Human Medicine, Michigan State University, Grand Rapids MI, USA. lineberr@msu.edu
Kyle D
KD
Lineberry
Adam K
AK
Boettcher
Andrew L
AL
Blount
Scott D
SD
Burgess
D000666:Amphotericin B / Q000008:administration & dosage; D000935:Antifungal Agents / Q000008:administration & dosage; D001916:Brachial Artery / Q000601:surgery; D003131:Combined Modality Therapy; D003646:Debridement; D004691:Endarterectomy / Q000009:adverse effects; D005260:Female; D006801:Humans; D006931:Hyperbaric Oxygenation; D007121:Immunocompetence; D008081:Liposomes; D008875:Middle Aged; D009091:Mucormycosis / Q000276:immunology / Q000628:therapy*; D011677:Punctures / Q000009:adverse effects*; D012233:Rhizopus; D012874:Skin Diseases, Infectious / Q000276:immunology / Q000382:microbiology / Q000628:therapy*; D016038:Skin Transplantation; D014955:Wrist Joint / Q000382:microbiology
D000935:Antifungal Agents; D008081:Liposomes; D000666:Amphotericin B